Managed Account Advisors’s Cantel Medical Corporation CMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q2
$4.02M Sell
74,946
-3,437
-4% -$167K ﹤0.01% 1525
2015
Q1
$3.72M Buy
78,383
+13,983
+22% +$619K ﹤0.01% 1572
2014
Q4
$2.79M Sell
64,400
-668
-1% -$27.3K ﹤0.01% 1671
2014
Q3
$2.24M Buy
65,068
+1,755
+3% +$62K ﹤0.01% 1755
2014
Q2
$2.32M Buy
63,313
+2,097
+3% +$71.1K ﹤0.01% 1724
2014
Q1
$2.06M Buy
61,216
+4,602
+8% +$152K ﹤0.01% 1727
2013
Q4
$1.92M Buy
56,614
+31,748
+128% +$1.1M ﹤0.01% 1737
2013
Q3
$792K Buy
24,866
+2,055
+9% +$54.7K ﹤0.01% 1923
2013
Q2
$515K Buy
+22,811
New +$494K ﹤0.01% 2004

Other funds holding CMD

Managed Account Advisors's CMD Position: Q2 2015 in Review

Managed Account Advisors reduced its Cantel Medical Corporation (CMD) stake by 4.4% in Q2 2015, selling an estimated $167K and leaving 74,946 shares worth $4.02M. The position accounts for ﹤0.01% of the portfolio, ranked #1525.

Managed Account Advisors first reported a position in CMD in Q2 2013 and has held it in 9 quarters since. 163 funds tracked by Wall St. Rank hold CMD as of Q2 2015.

  • Managed Account Advisors held 74,946 shares of Cantel Medical Corporation worth $4.02M as of Q2 2015.
  • Managed Account Advisors sold 3,437 Cantel Medical Corporation shares in Q2 2015, an estimated $167K.
  • Cantel Medical Corporation made up ﹤0.01% of Managed Account Advisors's portfolio in Q2 2015, its #1525 holding.
  • Managed Account Advisors first reported a position in Cantel Medical Corporation in Q2 2013 and has held it in 9 quarters since.
  • 163 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q2 2015.

Based on Managed Account Advisors's 13F filing for Q2 2015, filed 14 Aug 2015.